BICARA THERAPEUTICS INC (BCAX:NASDAQ)
$21.58 -0.4 (-1.8198%)
Analysed BICARA THERAPEUTICS INC (BCAX:NASDAQ) News Sources
Bicara Therapeutics Q1 Earnings Call Highlights
11-05-2026
marketbeat.com
Bicara Therapeutics Inc. Common Stock Q1 2026 Earnings Call Summary
11-05-2026
moby.co
Bicara Therapeutics Inc (BCAX) Q1 2026 Earnings Call Highlights: Strategic Advances and ...
12-05-2026
yahoo.com
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
13-05-2026
yahoo.com
Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data
14-05-2026
marketbeat.com
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
15-05-2026
fool.com
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet
15-05-2026
fool.com
A Look At Bicara Therapeutics (BCAX) Valuation After Recent Share Price Pullback
19-05-2026
yahoo.com
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
21-05-2026
yahoo.com
Bicara Therapeutics ASCO Data Bolster Ficerafusp Alfa in Head and Neck Cancer
22-05-2026
marketbeat.com
What is the current price of BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The current price of BICARA THERAPEUTICS INC (BCAX:NASDAQ) is $21.58.
BICARA THERAPEUTICS INC (BCAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BICARA THERAPEUTICS INC (BCAX:NASDAQ) since the previous trading day is $-0.4.
BICARA THERAPEUTICS INC (BCAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BICARA THERAPEUTICS INC (BCAX:NASDAQ) since the previous trading day is -1.8198%.
What is the most recent average sentiment score for BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The most recent average sentiment score for BICARA THERAPEUTICS INC (BCAX:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The most recent sentiment for BICARA THERAPEUTICS INC (BCAX:NASDAQ) is .
SEC-8K** Filing Available For BICARA THERAPEUTICS INC (BCAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.